Thought LeadersProfessor Karine Le RochDirector of the Center for Infectious Disease and Vector ResearchUniversity of California, Riverside As part of World Malaria Day 2022, we interview Karine Le ...

Interaction between LFA-1 on natural killer cells and GBP-130 on infected erythrocytes enables immune recognition and killing of Plasmodium falciparum-infected red blood cells.

Findings can open up new avenues for targeted approaches toward therapeutic strategies against the malaria-causing P. falciparum that are aimed at stopping the parasite's life cycle progression and ...

Currently licensed and approved malaria subunit vaccines provide modest, short-lived protection against malaria. Immunization with live-attenuated Plasmodium falciparum malaria parasites is an ...

All modern Plasmodium falciparum, the deadliest malaria parasite in humans, are descendants of one initial infection and so are very closely related, with relatively limited genetic differences. A ...

Researchers have developed a novel approach to analyzing malaria parasite genomes to reveal how antigenic variation arises. Researchers at the European Molecular Biology Laboratory’s European ...

This week, the carpeted halls of the Philadelphia Marriott echoed with a patois of West African French, Liverpudlian English and Brazilian Portuguese as researchers from around the globe converged for ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The ancient gene that gave rise to the deadliest disease in history has ...

Malaria that is caused by Plasmodium falciparum is a significant global health problem. Genetic characteristics of the host influence the severity of disease and the ultimate outcome of infection, and ...